Attention-deficit-hyperactivity disorder and reward deficiency syndrome K Blum, ALC Chen, ER Braverman, DE Comings, TJH Chen, V Arcuri, ... Neuropsychiatric disease and treatment 4 (5), 893-918, 2008 | 301 | 2008 |
Impaired action of anxiolytic drugs in mice deficient in cannabinoid CB1 receptors L Urigüen, S Pérez-Rial, C Ledent, T Palomo, J Manzanares Neuropharmacology 46 (7), 966-973, 2004 | 264 | 2004 |
The role of behavioral impulsivity in the development of alcohol dependence: a 4‐year follow‐up study G Rubio, M Jiménez, R Rodríguez‐Jiménez, I Martínez, C Ávila, F Ferre, ... Alcoholism: Clinical and Experimental Research 32 (9), 1681-1687, 2008 | 258 | 2008 |
Downregulation of rat brain cannabinoid binding sites after chronic Δ9-tetrahydrocannabinol treatment FR De Fonseca, MA Gorriti, JJ Fernandez-Ruiz, T Palomo, JA Ramos Pharmacology Biochemistry and Behavior 47 (1), 33-40, 1994 | 233 | 1994 |
Activation instead of blocking mesolimbic dopaminergic reward circuitry is a preferred modality in the long term treatment of reward deficiency syndrome (RDS): a commentary K Blum, ALC Chen, TJH Chen, ER Braverman, J Reinking, SH Blum, ... Theoretical Biology and Medical Modelling 5, 1-16, 2008 | 177 | 2008 |
Amisulpride and olanzapine followed by open-label treatment with clozapine in first-episode schizophrenia and schizophreniform disorder (OPTiMiSE): a three-phase switching study RS Kahn, IW van Rossum, S Leucht, P McGuire, SW Lewis, M Leboyer, ... The Lancet Psychiatry 5 (10), 797-807, 2018 | 175 | 2018 |
Negative signs and symptoms secondary to antipsychotics: a double-blind, randomized trial of a single dose of placebo, haloperidol, and risperidone in healthy volunteers JF Artaloytia, C Arango, A Lahti, J Sanz, A Pascual, P Cubero, D Prieto, ... American Journal of Psychiatry 163 (3), 488-493, 2006 | 172 | 2006 |
Chronic (−)-Δ9-tetrahydrocannabinol treatment induces sensitization to the psychomotor effects of amphetamine in rats MA Gorriti, FR de Fonseca, M Navarro, T Palomo European journal of pharmacology 365 (2-3), 133-142, 1999 | 166 | 1999 |
Impulsivity and sustained attention in pathological gamblers: influence of childhood ADHD history R Rodriguez-Jimenez, C Avila, MA Jimenez-Arriero, G Ponce, R Monasor, ... Journal of Gambling Studies 22, 451-461, 2006 | 164 | 2006 |
Naltrexone versus acamprosate: one year follow-up of alcohol dependence treatment G Rubio, MA Jimenez-Arriero, G Ponce, T Palomo Alcohol and Alcoholism 36 (5), 419-425, 2001 | 150 | 2001 |
The A1 allele of the DRD2 gene (TaqI A polymorphisms) is associated with antisocial personality in a sample of alcohol-dependent patients G Ponce, MA Jimenez-Arriero, G Rubio, J Hoenicka, I Ampuero, ... European Psychiatry 18 (7), 356-360, 2003 | 149 | 2003 |
Increase in gray matter and decrease in white matter volumes in the cortex during treatment with atypical neuroleptics in schizophrenia V Molina, S Reig, J Sanz, T Palomo, C Benito, J Sánchez, F Sarramea, ... Schizophrenia Research 80 (1), 61-71, 2005 | 131 | 2005 |
Cognition and the five-factor model of the positive and negative syndrome scale in schizophrenia R Rodriguez-Jimenez, A Bagney, L Mezquita, I Martinez-Gras, ... Schizophrenia research 143 (1), 77-83, 2013 | 129 | 2013 |
The ANKK1 Kinase Gene and Psychiatric Disorders G Ponce, R Pérez-González, M Aragüés, T Palomo, ... Neurotoxicity research 16, 50-59, 2009 | 114 | 2009 |
CHRONIC ETHANOL CONSUMPTION REGULATES CANNABINOID CB1 RECEPTOR GENE EXPRESSION IN SELECTED REGIONS OF RAT BRAIN S Ortiz, JM Oliva, S Pérez-Rial, T Palomo, J Manzanares Alcohol and alcoholism 39 (2), 88-92, 2004 | 113 | 2004 |
Clinical predictors of response to naltrexone in alcoholic patients: who benefits most from treatment with naltrexone? G Rubio, G Ponce, R Rodriguez-Jimenez, MA Jimenez-Arriero, ... Alcohol and Alcoholism 40 (3), 227-233, 2005 | 111 | 2005 |
(AAT) n repeat in the cannabinoid receptor gene, CNR1: association with schizophrenia in a Spanish population I Martínez-Gras, J Hoenicka, G Ponce, R Rodríguez–Jiménez, ... European Archives of Psychiatry and Clinical Neuroscience 256, 437-441, 2006 | 107 | 2006 |
Generational association studies of dopaminergic genes in reward deficiency syndrome (RDS) subjects: selecting appropriate phenotypes for reward dependence behaviors K Blum, ALC Chen, M Oscar-Berman, TJH Chen, J Lubar, N White, ... International Journal of Environmental Research and Public Health 8 (12 …, 2011 | 104 | 2011 |
DRD2 and ANKK1 genotype in alcohol-dependent patients with psychopathic traits: Association and interaction study G Ponce, J Hoenicka, MA Jimenez-Arriero, R Rodriguez-Jimenez, ... The British Journal of Psychiatry 193 (2), 121-125, 2008 | 103 | 2008 |
Incidence and lifetime risk of dementia and Alzheimer’s disease in a Southern European population A Lobo, R Lopez‐Anton, J Santabárbara, C De‐la‐Cámara, T Ventura, ... Acta Psychiatrica Scandinavica 124 (5), 372-383, 2011 | 96 | 2011 |